HEADER TRANSCRIPTION 29-JAN-07 2JF9 TITLE ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC TITLE 2 PEPTIDE ANTAGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN, RESIDUES 304-533; COMPND 5 SYNONYM: ER, ESTRADIOL RECEPTOR, ER-ALPHA, ESTROGEN RECEPTOR ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: AB5 PEPTIDE; COMPND 9 CHAIN: P, Q, R; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 12 ORGANISM_TAXID: 32630; SOURCE 13 OTHER_DETAILS: PEPTIDE DERIVED FROM PHAGE DISPLAY SCREEN OF RANDOM SOURCE 14 PEPTIDE LIBRARY KEYWDS TRANSCRIPTION FACTOR, LIPID-BINDING, TRANSCRIPTION, TRANSCRIPTION KEYWDS 2 REGULATION, LIGAND-BINDING DOMAIN (LBD), RECEPTOR, ZINC-FINGER, DNA- KEYWDS 3 BINDING, STEROID-BINDING, NUCLEAR RECEPTOR, PEPTIDE ANTAGONIST, KEYWDS 4 METAL-BINDING, NUCLEAR PROTEIN, PHOSPHORYLATION EXPDTA X-RAY DIFFRACTION AUTHOR N.HELDRING,T.PAWSON,D.MCDONNELL,E.TREUTER,J.A.GUSTAFSSON,A.C.W.PIKE REVDAT 7 13-DEC-23 2JF9 1 REMARK LINK REVDAT 6 24-JAN-18 2JF9 1 SOURCE REVDAT 5 21-DEC-16 2JF9 1 SOURCE AUTHOR REVDAT 4 13-JUL-11 2JF9 1 VERSN REVDAT 3 24-FEB-09 2JF9 1 VERSN REVDAT 2 10-APR-07 2JF9 1 JRNL REVDAT 1 20-FEB-07 2JF9 0 JRNL AUTH N.HELDRING,T.PAWSON,D.MCDONNELL,E.TREUTER,J.A.GUSTAFSSON, JRNL AUTH 2 A.C.W.PIKE JRNL TITL STRUCTURAL INSIGHTS INTO COREPRESSOR RECOGNITION BY JRNL TITL 2 ANTAGONIST-BOUND ESTROGEN RECEPTORS. JRNL REF J.BIOL.CHEM. V. 282 10449 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17283072 JRNL DOI 10.1074/JBC.M611424200 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 76697 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4054 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5663 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1920 REMARK 3 BIN FREE R VALUE SET COUNT : 284 REMARK 3 BIN FREE R VALUE : 0.2210 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5315 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 117 REMARK 3 SOLVENT ATOMS : 296 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 28.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.15000 REMARK 3 B22 (A**2) : -0.15000 REMARK 3 B33 (A**2) : 0.22000 REMARK 3 B12 (A**2) : -0.07000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.126 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.116 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.074 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.324 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5574 ; 0.012 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 3725 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7507 ; 1.266 ; 1.991 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9065 ; 1.717 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 667 ; 4.980 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 228 ;34.982 ;23.947 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1024 ;13.902 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;20.674 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 860 ; 0.077 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5974 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1036 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1228 ; 0.212 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3707 ; 0.174 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2690 ; 0.176 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2654 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 237 ; 0.129 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 17 ; 0.234 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 46 ; 0.302 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 16 ; 0.147 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3488 ; 0.810 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5415 ; 1.312 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2368 ; 1.892 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2092 ; 2.895 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 305 A 528 REMARK 3 RESIDUE RANGE : P 1 P 13 REMARK 3 ORIGIN FOR THE GROUP (A): 76.8750 39.2451 10.2447 REMARK 3 T TENSOR REMARK 3 T11: -0.0969 T22: -0.1826 REMARK 3 T33: -0.1027 T12: 0.0277 REMARK 3 T13: -0.0152 T23: 0.0051 REMARK 3 L TENSOR REMARK 3 L11: 3.5548 L22: 1.6063 REMARK 3 L33: 1.0886 L12: -0.6490 REMARK 3 L13: -0.1362 L23: -0.1850 REMARK 3 S TENSOR REMARK 3 S11: 0.0577 S12: 0.0587 S13: -0.0329 REMARK 3 S21: -0.1644 S22: -0.0358 S23: 0.2042 REMARK 3 S31: 0.0110 S32: -0.0933 S33: -0.0218 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 306 B 529 REMARK 3 RESIDUE RANGE : Q 1 Q 13 REMARK 3 ORIGIN FOR THE GROUP (A): 94.3276 22.5349 19.3205 REMARK 3 T TENSOR REMARK 3 T11: -0.0783 T22: -0.1845 REMARK 3 T33: -0.1758 T12: 0.0317 REMARK 3 T13: 0.0012 T23: 0.0004 REMARK 3 L TENSOR REMARK 3 L11: 1.2115 L22: 2.9097 REMARK 3 L33: 1.8739 L12: 0.1034 REMARK 3 L13: 0.2497 L23: -1.1251 REMARK 3 S TENSOR REMARK 3 S11: 0.0313 S12: -0.0417 S13: -0.0395 REMARK 3 S21: 0.0809 S22: 0.0234 S23: 0.0556 REMARK 3 S31: 0.1440 S32: -0.0354 S33: -0.0547 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 305 C 529 REMARK 3 RESIDUE RANGE : R 1 R 13 REMARK 3 ORIGIN FOR THE GROUP (A): 50.0407 61.1523 3.6085 REMARK 3 T TENSOR REMARK 3 T11: -0.1814 T22: -0.0417 REMARK 3 T33: -0.0852 T12: 0.0696 REMARK 3 T13: 0.0151 T23: 0.0323 REMARK 3 L TENSOR REMARK 3 L11: 1.5082 L22: 2.3575 REMARK 3 L33: 1.2188 L12: -0.7927 REMARK 3 L13: 0.1088 L23: -0.4329 REMARK 3 S TENSOR REMARK 3 S11: -0.0058 S12: -0.1339 S13: -0.3924 REMARK 3 S21: -0.0288 S22: 0.0389 S23: 0.2219 REMARK 3 S31: 0.1472 S32: -0.0307 S33: -0.0331 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2JF9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1290029157. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-FEB-05 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 80788 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.100 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2BJ4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5% PEG550MME 2.5% PEK20K 0.06M REMARK 280 CALCIUM ACETATE 0.1M TRIS PH8.5, PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.96067 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 21.48033 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 21.48033 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 42.96067 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DODECAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, P, Q, R REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 282 REMARK 465 GLY A 283 REMARK 465 SER A 284 REMARK 465 SER A 285 REMARK 465 HIS A 286 REMARK 465 HIS A 287 REMARK 465 HIS A 288 REMARK 465 HIS A 289 REMARK 465 HIS A 290 REMARK 465 HIS A 291 REMARK 465 SER A 292 REMARK 465 SER A 293 REMARK 465 GLY A 294 REMARK 465 LEU A 295 REMARK 465 VAL A 296 REMARK 465 PRO A 297 REMARK 465 ARG A 298 REMARK 465 GLY A 299 REMARK 465 SER A 300 REMARK 465 HIS A 301 REMARK 465 MET A 302 REMARK 465 GLU A 303 REMARK 465 ASN A 304 REMARK 465 PHE A 461 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 469 REMARK 465 LYS A 529 REMARK 465 CYS A 530 REMARK 465 LYS A 531 REMARK 465 ASN A 532 REMARK 465 VAL A 533 REMARK 465 MET B 282 REMARK 465 GLY B 283 REMARK 465 SER B 284 REMARK 465 SER B 285 REMARK 465 HIS B 286 REMARK 465 HIS B 287 REMARK 465 HIS B 288 REMARK 465 HIS B 289 REMARK 465 HIS B 290 REMARK 465 HIS B 291 REMARK 465 SER B 292 REMARK 465 SER B 293 REMARK 465 GLY B 294 REMARK 465 LEU B 295 REMARK 465 VAL B 296 REMARK 465 PRO B 297 REMARK 465 ARG B 298 REMARK 465 GLY B 299 REMARK 465 SER B 300 REMARK 465 HIS B 301 REMARK 465 MET B 302 REMARK 465 GLU B 303 REMARK 465 ASN B 304 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 PRO B 336 REMARK 465 PHE B 337 REMARK 465 SER B 338 REMARK 465 GLU B 339 REMARK 465 ALA B 340 REMARK 465 PHE B 461 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 CYS B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 VAL B 533 REMARK 465 MET C 282 REMARK 465 GLY C 283 REMARK 465 SER C 284 REMARK 465 SER C 285 REMARK 465 HIS C 286 REMARK 465 HIS C 287 REMARK 465 HIS C 288 REMARK 465 HIS C 289 REMARK 465 HIS C 290 REMARK 465 HIS C 291 REMARK 465 SER C 292 REMARK 465 SER C 293 REMARK 465 GLY C 294 REMARK 465 LEU C 295 REMARK 465 VAL C 296 REMARK 465 PRO C 297 REMARK 465 ARG C 298 REMARK 465 GLY C 299 REMARK 465 SER C 300 REMARK 465 HIS C 301 REMARK 465 MET C 302 REMARK 465 GLU C 303 REMARK 465 ASN C 304 REMARK 465 TYR C 459 REMARK 465 THR C 460 REMARK 465 PHE C 461 REMARK 465 LEU C 462 REMARK 465 SER C 463 REMARK 465 SER C 464 REMARK 465 THR C 465 REMARK 465 LEU C 466 REMARK 465 LYS C 467 REMARK 465 SER C 468 REMARK 465 LEU C 469 REMARK 465 CYS C 530 REMARK 465 LYS C 531 REMARK 465 ASN C 532 REMARK 465 VAL C 533 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 306 CD1 CD2 REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 GLU A 471 CG CD OE1 OE2 REMARK 470 LYS A 472 CD CE NZ REMARK 470 LYS A 492 CD CE NZ REMARK 470 TYR A 526 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 SER B 305 OG REMARK 470 LEU B 306 CG CD1 CD2 REMARK 470 ASP B 332 CG OD1 OD2 REMARK 470 GLU B 419 CB CG CD OE1 OE2 REMARK 470 LEU B 469 CD1 CD2 REMARK 470 GLU B 470 CG CD OE1 OE2 REMARK 470 GLU B 471 CG CD OE1 OE2 REMARK 470 LYS B 472 CG CD CE NZ REMARK 470 LYS B 492 NZ REMARK 470 TYR B 526 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 529 CD CE NZ REMARK 470 ARG C 335 CD NE CZ NH1 NH2 REMARK 470 ASN C 348 OD1 ND2 REMARK 470 GLU C 419 CG CD OE1 OE2 REMARK 470 GLU C 423 CG CD OE1 OE2 REMARK 470 LYS C 492 CE NZ REMARK 470 LYS C 520 CE NZ REMARK 470 TYR C 526 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS C 529 CG CD CE NZ REMARK 470 LYS P 9 CE NZ REMARK 470 GLU Q 6 CG CD OE1 OE2 REMARK 470 LYS R 9 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 436 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG B 515 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU B 408 84.16 -152.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA R1014 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 334 OG1 REMARK 620 2 HOH A2018 O 96.1 REMARK 620 3 ASP R 10 O 79.8 92.1 REMARK 620 4 SER R 13 OXT 73.1 163.7 74.2 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA P1014 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR C 334 OG1 REMARK 620 2 HOH C2021 O 82.0 REMARK 620 3 ASP P 10 O 81.6 82.3 REMARK 620 4 SER P 13 OXT 76.9 153.8 79.3 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BCT A 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA P 1014 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA R 1014 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OHT A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1529 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1530 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OHT B 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1530 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1531 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OHT C 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO C 1530 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO C 1531 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A52 RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL REMARK 900 RELATED ID: 1AKF RELATED DB: PDB REMARK 900 HOMOLOGOUS-EXTENSION-BASED MODEL OF HUMAN ESTROGEN RECEPTOR WITH REMARK 900 BOUND ESTRADIOL, THEORETICAL MODEL REMARK 900 RELATED ID: 1ERE RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 17BETA-ESTRADIOL REMARK 900 RELATED ID: 1ERR RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 RALOXIFENE REMARK 900 RELATED ID: 1G50 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9ANGSTROM REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1GWQ RELATED DB: PDB REMARK 900 HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX REMARK 900 WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE REMARK 900 RELATED ID: 1GWR RELATED DB: PDB REMARK 900 HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX REMARK 900 WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE REMARK 900 RELATED ID: 1HCP RELATED DB: PDB REMARK 900 RELATED ID: 1HCQ RELATED DB: PDB REMARK 900 RELATED ID: 1L2I RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 (R,R)-5,11-CIS- DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8- DIOL AND REMARK 900 A GLUCOCORTICOID RECEPTORINTERACTING PROTEIN 1 NR BOX II PEPTIDE REMARK 900 RELATED ID: 1PCG RELATED DB: PDB REMARK 900 HELIX-STABILIZED CYCLIC PEPTIDES AS SELECTIVE INHIBITORS OFSTEROID REMARK 900 RECEPTOR-COACTIVATOR INTERACTIONS REMARK 900 RELATED ID: 1QKT RELATED DB: PDB REMARK 900 RELATED ID: 1QKU RELATED DB: PDB REMARK 900 RELATED ID: 1R5K RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 GW5638 REMARK 900 RELATED ID: 1SJ0 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 THE ANTAGONIST LIGAND 4-D REMARK 900 RELATED ID: 1UOM RELATED DB: PDB REMARK 900 THE STRUCTURE OF ESTROGEN RECEPTOR IN COMPLEX WITH A SELECTIVE AND REMARK 900 POTENT TETRAHYDROISOCHIOLIN LIGAND. REMARK 900 RELATED ID: 1X7E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITHWAY-244 REMARK 900 RELATED ID: 1X7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITHGENISTEIN REMARK 900 RELATED ID: 1XP1 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 15 REMARK 900 RELATED ID: 1XP6 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 16 REMARK 900 RELATED ID: 1XP9 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 18 REMARK 900 RELATED ID: 1XPC RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 19 REMARK 900 RELATED ID: 1XQC RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF ERALPHA LBD BOUND TO ATETRAHYDROISOQUINOLINE REMARK 900 SERM LIGAND AT 2.05A RESOLUTION REMARK 900 RELATED ID: 1YIM RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 4 REMARK 900 RELATED ID: 1YIN RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 3F REMARK 900 RELATED ID: 1ZKY RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 OBCP-3M AND A GLUCOCORTICOID RECEPTORINTERACTING PROTEIN 1 NR BOX REMARK 900 II PEPTIDE REMARK 900 RELATED ID: 2AYR RELATED DB: PDB REMARK 900 A SERM DESIGNED FOR THE TREATMENT OF UTERINE LEIOMYOMA WITHUNIQUE REMARK 900 TISSUE SPECIFICITY FOR UTERUS AND OVARIES IN RATS REMARK 900 RELATED ID: 2B1V RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 OBCP-1M AND A GLUCOCORTICOID RECEPTORINTERACTING PROTEIN 1 NR BOX REMARK 900 II PEPTIDE REMARK 900 RELATED ID: 2BJ4 RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED REMARK 900 PEPTIDE ANTAGONIST REMARK 900 RELATED ID: 2FAI RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 OBCP-2M AND A GLUCOCORTICOID RECEPTORINTERACTING PROTEIN 1 NR BOX REMARK 900 II PEPTIDE REMARK 900 RELATED ID: 3ERD RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 DIETHYLSTILBESTROL AND A GLUCOCORTICOIDRECEPTOR INTERACTING PROTEIN REMARK 900 1 NR BOX II PEPTIDE REMARK 900 RELATED ID: 3ERT RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 4-HYDROXYTAMOXIFEN REMARK 900 RELATED ID: 2JFA RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED REMARK 900 COREPRESSOR PEPTIDE DBREF 2JF9 A 282 303 PDB 2JF9 2JF9 282 303 DBREF 2JF9 A 304 533 UNP P03372 ESR1_HUMAN 304 533 DBREF 2JF9 B 282 303 PDB 2JF9 2JF9 282 303 DBREF 2JF9 B 304 533 UNP P03372 ESR1_HUMAN 304 533 DBREF 2JF9 C 282 303 PDB 2JF9 2JF9 282 303 DBREF 2JF9 C 304 533 UNP P03372 ESR1_HUMAN 304 533 DBREF 2JF9 P 1 13 PDB 2JF9 2JF9 1 13 DBREF 2JF9 Q 1 13 PDB 2JF9 2JF9 1 13 DBREF 2JF9 R 1 13 PDB 2JF9 2JF9 1 13 SEQRES 1 A 252 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 252 LEU VAL PRO ARG GLY SER HIS MET GLU ASN SER LEU ALA SEQRES 3 A 252 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 4 A 252 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 5 A 252 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 6 A 252 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 7 A 252 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 8 A 252 HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU GLU SEQRES 9 A 252 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 10 A 252 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 11 A 252 ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL GLU ILE SEQRES 12 A 252 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 13 A 252 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 14 A 252 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 15 A 252 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 16 A 252 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 17 A 252 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 18 A 252 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 19 A 252 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 20 A 252 LYS CYS LYS ASN VAL SEQRES 1 B 252 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 252 LEU VAL PRO ARG GLY SER HIS MET GLU ASN SER LEU ALA SEQRES 3 B 252 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 4 B 252 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 5 B 252 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 6 B 252 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 7 B 252 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 8 B 252 HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU GLU SEQRES 9 B 252 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 10 B 252 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 11 B 252 ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL GLU ILE SEQRES 12 B 252 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 13 B 252 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 14 B 252 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 15 B 252 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 16 B 252 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 17 B 252 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 18 B 252 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 19 B 252 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 20 B 252 LYS CYS LYS ASN VAL SEQRES 1 C 252 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 C 252 LEU VAL PRO ARG GLY SER HIS MET GLU ASN SER LEU ALA SEQRES 3 C 252 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 4 C 252 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 5 C 252 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 6 C 252 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 7 C 252 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 8 C 252 HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU GLU SEQRES 9 C 252 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 10 C 252 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 11 C 252 ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL GLU ILE SEQRES 12 C 252 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 13 C 252 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 14 C 252 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 15 C 252 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 16 C 252 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 17 C 252 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 18 C 252 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 19 C 252 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 20 C 252 LYS CYS LYS ASN VAL SEQRES 1 P 13 SER PRO GLY SER ARG GLU TRP PHE LYS ASP MET LEU SER SEQRES 1 Q 13 SER PRO GLY SER ARG GLU TRP PHE LYS ASP MET LEU SER SEQRES 1 R 13 SER PRO GLY SER ARG GLU TRP PHE LYS ASP MET LEU SER HET OHT A 600 29 HET BCT A 700 4 HET EDO A1529 4 HET EDO A1530 4 HET OHT B 600 29 HET EDO B1530 4 HET EDO B1531 4 HET OHT C 600 29 HET EDO C1530 4 HET EDO C1531 4 HET CA P1014 1 HET CA R1014 1 HETNAM OHT 4-HYDROXYTAMOXIFEN HETNAM BCT BICARBONATE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM CA CALCIUM ION HETSYN EDO ETHYLENE GLYCOL FORMUL 7 OHT 3(C26 H29 N O2) FORMUL 8 BCT C H O3 1- FORMUL 9 EDO 6(C2 H6 O2) FORMUL 17 CA 2(CA 2+) FORMUL 19 HOH *296(H2 O) HELIX 1 1 SER A 305 LEU A 310 1 6 HELIX 2 2 THR A 311 ALA A 322 1 12 HELIX 3 3 SER A 338 VAL A 364 1 27 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 MET A 396 1 26 HELIX 6 6 ARG A 412 LYS A 416 1 5 HELIX 7 7 GLY A 420 ASN A 439 1 20 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 GLU A 470 ALA A 493 1 24 HELIX 10 10 THR A 496 MET A 528 1 33 HELIX 11 11 LEU B 306 LEU B 310 5 5 HELIX 12 12 THR B 311 ALA B 322 1 12 HELIX 13 13 SER B 341 ARG B 363 1 23 HELIX 14 14 GLY B 366 LEU B 370 5 5 HELIX 15 15 THR B 371 MET B 396 1 26 HELIX 16 16 ASN B 413 VAL B 418 5 6 HELIX 17 17 GLY B 420 ASN B 439 1 20 HELIX 18 18 GLN B 441 SER B 456 1 16 HELIX 19 19 LEU B 469 ALA B 493 1 25 HELIX 20 20 THR B 496 LYS B 529 1 34 HELIX 21 21 SER C 305 LEU C 310 5 6 HELIX 22 22 THR C 311 ALA C 322 1 12 HELIX 23 23 SER C 338 ARG C 363 1 26 HELIX 24 24 GLY C 366 LEU C 370 5 5 HELIX 25 25 THR C 371 SER C 395 1 25 HELIX 26 26 ARG C 412 LYS C 416 1 5 HELIX 27 27 GLY C 420 MET C 438 1 19 HELIX 28 28 GLN C 441 SER C 456 1 16 HELIX 29 29 ASP C 473 ALA C 493 1 21 HELIX 30 30 THR C 496 LYS C 529 1 34 HELIX 31 31 SER P 4 SER P 13 1 10 HELIX 32 32 SER Q 4 SER Q 13 1 10 HELIX 33 33 SER R 4 SER R 13 1 10 SHEET 1 AA 2 LYS A 401 ALA A 405 0 SHEET 2 AA 2 LEU A 408 ASP A 411 -1 O LEU A 408 N ALA A 405 SHEET 1 BA 2 LYS B 401 ALA B 405 0 SHEET 2 BA 2 LEU B 408 ASP B 411 -1 O LEU B 408 N ALA B 405 SHEET 1 CA 2 LYS C 401 ALA C 405 0 SHEET 2 CA 2 LEU C 408 ASP C 411 -1 O LEU C 408 N ALA C 405 LINK OG1 THR A 334 CA CA R1014 1555 1555 2.55 LINK O HOH A2018 CA CA R1014 1555 1555 2.45 LINK OG1 THR C 334 CA CA P1014 1555 1555 2.55 LINK O HOH C2021 CA CA P1014 1555 1555 2.39 LINK O ASP P 10 CA CA P1014 1555 1555 2.43 LINK OXT SER P 13 CA CA P1014 1555 1555 2.20 LINK O ASP R 10 CA CA R1014 1555 1555 2.48 LINK OXT SER R 13 CA CA R1014 1555 1555 2.51 SITE 1 AC1 7 LEU A 327 TYR A 328 ARG A 352 ILE C 326 SITE 2 AC1 7 LEU C 327 TYR C 328 ARG C 352 SITE 1 AC2 4 THR C 334 HOH C2021 ASP P 10 SER P 13 SITE 1 AC3 4 THR A 334 HOH A2018 ASP R 10 SER R 13 SITE 1 AC4 16 MET A 343 LEU A 346 THR A 347 ALA A 350 SITE 2 AC4 16 ASP A 351 GLU A 353 TRP A 383 LEU A 384 SITE 3 AC4 16 ARG A 394 PHE A 404 MET A 421 LEU A 428 SITE 4 AC4 16 GLY A 521 HIS A 524 LEU A 525 PRO P 2 SITE 1 AC5 5 TYR A 331 PRO A 333 ASN A 407 HOH A2095 SITE 2 AC5 5 ASN C 359 SITE 1 AC6 4 GLU A 323 TRP A 393 GLY A 442 HOH A2096 SITE 1 AC7 13 MET B 343 LEU B 346 THR B 347 ALA B 350 SITE 2 AC7 13 ASP B 351 GLU B 353 LEU B 384 ARG B 394 SITE 3 AC7 13 PHE B 404 MET B 421 LEU B 428 GLY B 521 SITE 4 AC7 13 PRO Q 2 SITE 1 AC8 5 TYR A 459 MET B 427 THR B 431 HIS B 513 SITE 2 AC8 5 HIS B 516 SITE 1 AC9 4 LEU B 320 GLU B 323 TRP B 393 GLY B 442 SITE 1 BC1 13 MET C 343 LEU C 346 ALA C 350 ASP C 351 SITE 2 BC1 13 GLU C 353 ARG C 394 MET C 421 ILE C 424 SITE 3 BC1 13 LEU C 428 HIS C 524 LEU C 525 SER R 1 SITE 4 BC1 13 PRO R 2 SITE 1 BC2 4 VAL A 355 ASN A 359 TYR C 331 ASN C 407 SITE 1 BC3 4 LEU C 320 GLU C 323 TRP C 393 GLY C 442 CRYST1 193.707 193.707 64.441 90.00 90.00 120.00 P 32 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005162 0.002981 0.000000 0.00000 SCALE2 0.000000 0.005961 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015518 0.00000 MTRIX1 1 0.132000 0.767000 -0.628000 60.20348 1 MTRIX2 1 0.764000 -0.482000 -0.429000 -13.82353 1 MTRIX3 1 -0.631000 -0.423000 -0.650000 91.19273 1 MTRIX1 2 -0.152000 0.950000 -0.274000 27.10186 1 MTRIX2 2 0.946000 0.059000 -0.320000 -10.80612 1 MTRIX3 2 -0.287000 -0.307000 -0.907000 46.94690 1 MTRIX1 3 0.004000 0.751000 -0.661000 69.58496 1 MTRIX2 3 0.736000 -0.449000 -0.506000 -13.06248 1 MTRIX3 3 -0.677000 -0.484000 -0.554000 95.84724 1 MTRIX1 4 -0.158000 0.948000 -0.278000 27.91552 1 MTRIX2 4 0.946000 0.065000 -0.318000 -11.17572 1 MTRIX3 4 -0.283000 -0.313000 -0.907000 46.88354 1